These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3109286)

  • 1. Effect on the seizure threshold in dogs of tocainide/lidocaine administration.
    Schuster MR; Paris PM; Kaplan RM; Stewart RD
    Ann Emerg Med; 1987 Jul; 16(7):749-51. PubMed ID: 3109286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic effects of tocainide and lidocaine in dogs.
    Aberg G; Ronfeld R; Aberg L; Fitzgerald T; McCollom K; Moller R
    Acta Pharmacol Toxicol (Copenh); 1983 Aug; 53(2):146-52. PubMed ID: 6414246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A seizure induced by concurrent lidocaine-tocainide therapy--is it just a case of additive toxicity?
    Forrence E; Covinsky JO; Mullen C
    Drug Intell Clin Pharm; 1986 Jan; 20(1):56-9. PubMed ID: 3080299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized double-blind study of intravenous tocainide versus lidocaine for suppression of ventricular arrhythmias after cardiac surgery.
    Manolis AS; Smith E; Payne D; Rastegar H; Cleveland R; Estes NA
    Clin Cardiol; 1990 Mar; 13(3):177-81. PubMed ID: 2108835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic tocainide or lidocaine in acute myocardial infarction.
    Keefe DL; Williams S; Torres V; Flowers D; Somberg JC
    Am J Cardiol; 1986 Mar; 57(8):527-31. PubMed ID: 3082175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction.
    Wallace AA; Stupienski RF; Heaney LA; Gehret JR; Lynch JJ
    Am Heart J; 1991 May; 121(5):1413-21. PubMed ID: 1708198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocainide and mortality after myocardial infarction: a prospective study in conscious dogs.
    Vanoli E; Hull SS; Stith RD; Adamson PB; Foreman RD; Schwartz PJ
    J Am Coll Cardiol; 1990 Nov; 16(6):1475-80. PubMed ID: 2121814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation.
    Uprichard AC; Allen JD; Harron DW
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):235-41. PubMed ID: 2452320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose finding of tocainide in the treatment of tinnitus.
    Vermeij P; Hulshof JH
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):207-12. PubMed ID: 3086242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK; Mahapatra D
    Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intra-venous lidocaine and several different doses oral tocainide HCl on tinnitus. A dose-finding study.
    Hulshof JH; Vermeij P
    Acta Otolaryngol; 1984; 98(3-4):231-8. PubMed ID: 6437131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of R- and S-tocainide in patients with acute ventricular arrhythmias.
    Thomson AH; Murdoch G; Pottage A; Kelman AW; Whiting B; Hillis WS
    Br J Clin Pharmacol; 1986 Feb; 21(2):149-54. PubMed ID: 3082345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias.
    Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML
    Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocainide suppression of immune-complex-mediated dermal inflammation: comparison with prostaglandin E1.
    White RH; Robbins DL; Henderson GL; Hyde DM
    Clin Immunol Immunopathol; 1986 Jun; 39(3):452-63. PubMed ID: 2938861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tocainide, an oral analogue of lidocaine, on thromboembolism after total hip replacement.
    Modig J; Borg T; Karlström G; Sahlstedt B; Rikner L
    Ups J Med Sci; 1981; 86(3):269-78. PubMed ID: 6798734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal intoxication by tocainide.
    Sperry K; Wohlenberg N; Standefer JC
    J Forensic Sci; 1987 Sep; 32(5):1440-6. PubMed ID: 3117960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.
    Ryan W; Engler R; LeWinter M; Karliner JS
    Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent.
    Morganroth J; Nestico PF; Horowitz LN
    Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocainide. A review of its pharmacological properties and therapeutic efficacy.
    Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.